Whole Exome Sequencing Worth It? Cost vs. Benefits in India

Is Whole Exome Sequencing Worth It? Cost vs. Benefits in India

Whole exome sequencing (WES) is one of the most powerful genetic tests available — analysing all 20,000+ protein-coding genes in your genome to identify the cause of rare diseases, guide cancer treatment, and inform family planning decisions. But is it worth the cost? Here’s everything you need to know.

What is Whole Exome Sequencing?

The exome is the portion of your genome that codes for proteins — approximately 1–2% of your total DNA, but responsible for about 85% of known disease-causing mutations. WES sequences all of these coding regions simultaneously, making it far more comprehensive than targeted gene panels.

What Can WES Diagnose?

• Rare and undiagnosed diseases — WES has a diagnostic yield of 25–40% for patients with rare conditions who have had no previous diagnosis

• Inherited genetic disorders — including metabolic disorders, neurological conditions, and skeletal dysplasias

• Cancer genomics — identifying somatic mutations to guide targeted therapy

• Paediatric conditions — particularly for children with developmental delays, intellectual disability, or multiple congenital anomalies

Cost of Whole Exome Sequencing in India

WES costs in India typically range from ₹15,000 to ₹60,000 depending on the laboratory, turnaround time, and whether clinical interpretation and genetic counselling are included. MapmyGenome offers WES through NABL-accredited laboratories with expert genetic counselling support.

Benefits vs. Limitations

Benefits

• Comprehensive — analyses all protein-coding genes in one test

• High diagnostic yield for rare and undiagnosed conditions

• Can end the “diagnostic odyssey” that takes families years to navigate

• Results can guide treatment, family planning, and cascade testing

Limitations

• Does not sequence non-coding regions (unlike whole genome sequencing)

• Variants of uncertain significance (VUS) can be difficult to interpret

• Requires expert genetic counselling to interpret results correctly

Who Should Consider WES?

• Patients with rare or undiagnosed conditions after standard testing

• Children with developmental delays, intellectual disability, or multiple anomalies

• Families with a history of rare genetic disorders

• Cancer patients requiring targeted therapy guidance